A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin 1 predicts survival in patients with advanced gastric cancer

Aktas S. H., AKBULUT H., Yazici O., Zengin N., Akgun H. N., Ustuner Z., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.2, pp.399-406, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.3906/sag-1509-80
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.399-406
  • Keywords: Docetaxel, cisplatin, 5-fluorouracil, VEGFA, angiopoietin 1, placental growth factor, angiogenesis prognostic index, gastric cancer, ENDOTHELIAL-GROWTH-FACTOR, GASTROESOPHAGEAL JUNCTION, HEPATOCELLULAR-CARCINOMA, VASCULAR MORPHOGENESIS, COLORECTAL-CANCER, CHEMOTHERAPY, EXPRESSION, CISPLATIN, THERAPY, METAANALYSIS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background/aim: The role of angiogenic factors in gastric cancer is not clear. We aimed to assess the role of vascular endothelial growth factor A (VEGFA), angiopoietin 1 (Ang-1), and placental growth factor (PlGF) in the prognosis of patients with advanced gastric cancer.